# |
PMID |
Sentence |
1 |
17291641
|
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
|
2 |
17291641
|
Plasma levels of PF-4 and beta-TG, platelet activation markers were measured using commercial ELISA kit.
|
3 |
17291641
|
PF-4 and beta-TG basal levels were not significantly different between the patients and the healthy subjects.
|
4 |
17291641
|
Thus, it seems that the degree of platelet activation measured by PF-4 and beta-TG does not change in PAR patients during hyposensitization with mite allergen extracts, after the maximum dose was reached.
|
5 |
17291641
|
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
|
6 |
17291641
|
Plasma levels of PF-4 and beta-TG, platelet activation markers were measured using commercial ELISA kit.
|
7 |
17291641
|
PF-4 and beta-TG basal levels were not significantly different between the patients and the healthy subjects.
|
8 |
17291641
|
Thus, it seems that the degree of platelet activation measured by PF-4 and beta-TG does not change in PAR patients during hyposensitization with mite allergen extracts, after the maximum dose was reached.
|
9 |
17291641
|
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
|
10 |
17291641
|
Plasma levels of PF-4 and beta-TG, platelet activation markers were measured using commercial ELISA kit.
|
11 |
17291641
|
PF-4 and beta-TG basal levels were not significantly different between the patients and the healthy subjects.
|
12 |
17291641
|
Thus, it seems that the degree of platelet activation measured by PF-4 and beta-TG does not change in PAR patients during hyposensitization with mite allergen extracts, after the maximum dose was reached.
|
13 |
17291641
|
Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
|
14 |
17291641
|
Plasma levels of PF-4 and beta-TG, platelet activation markers were measured using commercial ELISA kit.
|
15 |
17291641
|
PF-4 and beta-TG basal levels were not significantly different between the patients and the healthy subjects.
|
16 |
17291641
|
Thus, it seems that the degree of platelet activation measured by PF-4 and beta-TG does not change in PAR patients during hyposensitization with mite allergen extracts, after the maximum dose was reached.
|
17 |
19552626
|
The specificity for human substrates is not restricted to IL-8, since we also detected in vitro protease activity for another CXC chemokine GRO-alpha (growth-related oncogene alpha), but not for NAP-2 (neutrophil-activating protein 2), SDF (stromal-cell-derived factor)-1alpha, PF-4 (platelet factor 4), I-TAC (interferon-gamma-inducible T-cell alpha-chemoattractant), IP-10 (interferon-gamma-inducible protein 10) and MCP-1 (monocyte chemoattractant protein 1).
|